1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Roesch, P. Marx, U.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H6 O4 118.088 SUCCINIC ACID non-polymer C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking Bayreuth : University of Bayreuth (Thesis) GW Strukturen Verschiedener Parathormonfragmente in Loesung 2123 -1 1996 10.2210/pdb1zwg/pdb pdb_00001zwg 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4235.930 PARATHYROID HORMONE 4 - 37 N-TERMINAL SUCCINYLATED 1 man polymer N-SUCCINYL-HPTH(4-37) no yes (SIN)EIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL XEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample POTENTIAL 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conn repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-06-16 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag Y BNL 1996-06-17 REL 10 BRUNGER refinement X-PLOR 3.1 SIN 1 n 1 SIN 1 A GLU 2 n 2 GLU 2 A ILE 3 n 3 ILE 3 A GLN 4 n 4 GLN 4 A LEU 5 n 5 LEU 5 A MET 6 n 6 MET 6 A HIS 7 n 7 HIS 7 A ASN 8 n 8 ASN 8 A LEU 9 n 9 LEU 9 A GLY 10 n 10 GLY 10 A LYS 11 n 11 LYS 11 A HIS 12 n 12 HIS 12 A LEU 13 n 13 LEU 13 A ASN 14 n 14 ASN 14 A SER 15 n 15 SER 15 A MET 16 n 16 MET 16 A GLU 17 n 17 GLU 17 A ARG 18 n 18 ARG 18 A VAL 19 n 19 VAL 19 A GLU 20 n 20 GLU 20 A TRP 21 n 21 TRP 21 A LEU 22 n 22 LEU 22 A ARG 23 n 23 ARG 23 A LYS 24 n 24 LYS 24 A LYS 25 n 25 LYS 25 A LEU 26 n 26 LEU 26 A GLN 27 n 27 GLN 27 A ASP 28 n 28 ASP 28 A VAL 29 n 29 VAL 29 A HIS 30 n 30 HIS 30 A ASN 31 n 31 ASN 31 A PHE 32 n 32 PHE 32 A VAL 33 n 33 VAL 33 A ALA 34 n 34 ALA 34 A LEU 35 n 35 LEU 35 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 18 0.317 SIDE CHAIN 1 A ARG 23 0.317 SIDE CHAIN 2 A ARG 18 0.317 SIDE CHAIN 2 A ARG 23 0.316 SIDE CHAIN 3 A ARG 18 0.314 SIDE CHAIN 3 A ARG 23 0.316 SIDE CHAIN 4 A ARG 18 0.295 SIDE CHAIN 4 A ARG 23 0.305 SIDE CHAIN 5 A ARG 18 0.236 SIDE CHAIN 5 A ARG 23 0.307 SIDE CHAIN 6 A ARG 18 0.316 SIDE CHAIN 6 A ARG 23 0.316 SIDE CHAIN 7 A ARG 18 0.312 SIDE CHAIN 7 A ARG 23 0.307 SIDE CHAIN 8 A ARG 18 0.317 SIDE CHAIN 8 A ARG 23 0.303 SIDE CHAIN 9 A ARG 18 0.315 SIDE CHAIN 9 A ARG 23 0.315 SIDE CHAIN 10 A ARG 18 0.302 SIDE CHAIN 10 A ARG 23 0.317 SIDE CHAIN 1 A ILE 3 -122.81 -55.08 1 A HIS 12 -81.22 -93.24 1 A LEU 13 50.31 -155.11 1 A ASN 14 -164.52 79.17 1 A SER 15 52.00 -78.12 1 A ASN 31 -179.45 -52.17 1 A VAL 33 171.84 90.46 1 A ALA 34 -176.57 -71.49 2 A ASN 14 -172.31 -41.10 2 A SER 15 -139.25 -72.33 2 A GLN 27 -95.95 33.42 2 A HIS 30 -44.11 92.55 2 A ASN 31 76.66 -65.62 2 A PHE 32 -180.00 -94.77 2 A VAL 33 24.18 48.36 2 A ALA 34 -149.35 23.20 3 A HIS 12 27.00 63.98 3 A ASN 14 130.31 161.86 3 A HIS 30 -97.13 50.03 3 A ASN 31 -156.90 -49.28 3 A PHE 32 -67.08 81.00 4 A ASN 8 -80.53 41.35 4 A LYS 11 87.20 -61.65 4 A HIS 12 153.83 -21.37 4 A LEU 13 33.21 -154.57 4 A ASN 14 -172.03 -47.80 4 A SER 15 -144.85 -78.91 4 A GLN 27 -97.77 -79.16 4 A ASP 28 65.32 -71.62 4 A PHE 32 -99.33 38.17 4 A VAL 33 74.08 -63.60 4 A ALA 34 77.57 -62.51 5 A LEU 13 -129.75 -90.80 5 A ASN 14 175.76 -86.62 5 A SER 15 -161.14 -60.57 5 A GLN 27 -102.73 44.35 5 A VAL 29 -99.75 48.87 5 A HIS 30 -141.17 -52.69 5 A VAL 33 69.28 80.94 6 A LEU 13 -132.90 -56.06 6 A ASN 14 176.34 160.95 6 A GLN 27 -89.77 -77.38 6 A VAL 29 -178.89 -47.56 6 A PHE 32 -166.46 -142.06 7 A LEU 13 22.25 -100.80 7 A ASN 14 -164.09 -80.07 7 A SER 15 -146.04 -66.61 7 A GLN 27 -96.94 42.03 7 A HIS 30 -20.18 -51.51 7 A ASN 31 -156.00 27.09 7 A PHE 32 44.47 94.65 7 A VAL 33 37.41 52.64 7 A ALA 34 -128.30 -153.05 8 A ASN 8 -86.88 38.11 8 A LEU 9 -130.38 -63.28 8 A ASN 14 176.76 151.87 8 A SER 15 44.09 -83.83 8 A GLN 27 -91.81 59.61 8 A HIS 30 15.38 -102.12 8 A PHE 32 146.42 -32.10 8 A VAL 33 -55.85 89.12 9 A ASN 14 178.92 -46.12 9 A SER 15 -135.74 -81.10 9 A GLN 27 -82.00 -96.42 9 A ASP 28 68.29 -59.54 9 A HIS 30 -21.76 -51.11 9 A ASN 31 -143.47 12.06 9 A PHE 32 47.31 86.65 9 A ALA 34 -126.45 -62.99 10 A GLN 4 77.76 -58.02 10 A LEU 9 -109.65 -68.25 10 A GLN 27 -69.64 -76.61 10 A ASP 28 42.45 85.05 10 A VAL 29 82.96 -51.86 10 A HIS 30 28.68 82.36 10 A ASN 31 76.74 -52.13 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 SUCCINYL HUMAN PARATHYROID HORMONE 4-37, NMR, 10 STRUCTURES 1 Y N A ILE 3 A ILE 3 HELX_P A GLY 10 A GLY 10 1 1 8 A MET 16 A MET 16 HELX_P A LEU 26 A LEU 26 1 2 11 covale 1.325 both A SIN 1 A C4 SIN 1 1_555 A GLU 2 A N GLU 2 1_555 HORMONE HORMONE, DISEASE MUTATION PTHY_HUMAN UNP 1 1 P01270 MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ 35 68 1ZWG 2 35 P01270 A 1 2 35 1 P 1